Indications
Diroximel Fumarate is used to treat relapsing forms of multiple sclerosis (MS) in adults. This includes clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Nobody knows how diroximel fumarate works in multiple sclerosis. Its active metabolite, MMF, has been shown to activate the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway, in vitro and in vivo, in animals and humans. This pathway is involved in the cell's response to oxidative stress. MMF has also been identified as a nicotinic acid receptor agonist in vitro.
Pregnancy & Breastfeeding
We don't have enough data to say what risk Diroximel fumarate carries for development when it is used in pregnant women. The same is true of dimethyl fumarate, which has the same active metabolite as Diroximel. Nobody has measured whether diroximel fumarate or its metabolites (MMF, HES) pass into human milk. So the effects on a breastfed infant, and on milk production, are not known.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.